Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes

European Journal of Immunology

Volumn 32, Issue 1, 2002, Pages 67-76

  Triggiani, Massimo ^a   Granata, Francescopaolo ^a   Oriente, Alfonso ^a   Gentile, Marco ^a   Petraroli, Angelica ^a   Balestrieri, Barbara ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cytokine; IL 6; Monocyte; Secretory phospholipase A2; TNF

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; PHOSPHOLIPASE A2; SECRETORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA; GROUP II SECRETORY PHOSPHOLIPASE A2; PHOSPHOLIPASE A; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMAL; ARACHIDONIC ACID; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; HUMAN; INTERLEUKIN-12; INTERLEUKIN-6; MONOCYTES; PHOSPHOLIPASES A; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR;

EID: 0036006685     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200201)32:1<67::AID-IMMU67>3.0.CO;2-3     Document Type: Article

References (58)

1. 2
2. 2(s); comparison of arachidonoyl-selective and -nonselective enzymes
3. 2
4. 2
5. 2 gene family in mammals
6. 2 from synovial fluid in rheumatoid arthritis
7. 2 from human synovial fluid in rheumatoid arthritis
8. 2 present in rheumatoid arthritic synovial fluid
9. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics
10. 2 from human nasal lavage
11. 2 levels: Ccorrelation with the hemodynamic and pulmonary changes in gram-negative septic shock
12. 2 in human acute pancreatitis
13. 2, cytokines and eicosanoids in patients with burns
14. 2 in the pathobiology of disease
15. 2
16. 2
17. 2 in rabbits
18. 2
19. 2 induces an inflammatory response in rabbit joints
20. 2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes
21. 2
22. 2 in rat chondrocyte via its specific binding sites
23. 2 induce beta-glucuronidase release and IL-6 production from human lung macrophages
24. 2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-kappa B activation
25. 2 in murine bone marrow-derived mast cells
26. Current concepts: Immunology. Monocytes and macrophages
27. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus
28. The pathogenesis of atherosclerosis: A perspective for the 1990s
29. Leukocyte activation in sepsis; correlations with disease state and mortality
30. 2-a mediator between proximal and distal effectors of inflammation
31. 2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients
32. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease
33. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells
34. 2 inhibitor
35. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets
36. 2 and development of a radioimmunoassay
37. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis
38. 2 in human atherosclerotic plaques
39. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
40. Location of tumour necrosis factor alpha by immuno-histochemistry in chronic inflammatory bowel disease
41. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
42. IL-6 and NF-IL6 in acute-phase response and viral infection
43. Tumor necrosis factor: Biology and therapeutic inhibitors
44. 2 in human synovial cells
45. 2 gene expression in human hepatoma cells by mediators of the acute phase response
46. 2 synthesis
47. 2-agonists prevent Th1 development by selective inhibition of interleukin 12
48. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases
49. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor alpha production
50. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes
51. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine
52. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
53. 2 involved in N-type receptor binding and neurotoxicity
54. Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages
55. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
56. Protein measurement with the folin phenol reagent
57. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage